mckinsey oxycontin news - Search News

McKinsey to pay $650 million

ABC on MSN · 20h

McKinsey to pay $650 million over role in OxyContin epidemic

McKinsey agreed to pay $650 million as part of a deferred prosecution agreement, according to court documents filed Friday. As part of the agreement, McKinsey will "not do any work related to the marketing, sale, promotion or distribution of controlled substances" and will not contest the facts of the government's criminal charges.

The New York Times · 2d

McKinsey to Pay $650 Million in Opioid Settlement With Justice Department

McKinsey & Company has agreed to pay $650 million to settle a Justice Department investigation of its work with the opioid maker Purdue Pharma. A former senior partner has also agreed to plead guilty to obstruction of justice for destroying internal company records in connection with that work.

USA TODAY on MSN · 2d

McKinsey to pay $650 million after advising opioid maker on how to 'turbocharge' sales

McKinsey & Company agreed to pay $650 million to resolve criminal and civil investigations into its advice to opioids manufacturer Purdue Pharma.

Hosted on MSN1d

‘Source Of Profound Regret’: McKinsey Pays Half Billion Settlement To Avoid Prosecution For Fueling Opioid Crisis

A consulting giant that helped fuel the United States’ deadly opioid epidemic agreed to pay a massive settlement to avoid ...

CNN on MSN2d

Consulting firm McKinsey to pay $650 million to resolve US criminal opioid probe

McKinsey & Co has agreed to pay $650 million to resolve a US Department of Justice investigation into the consulting firm’s ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results